Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/26/18 | 3 | Initial statement of beneficial ownership of securities |
|
3 | |
| 12/26/18 | 8-K | Current report filing |
|
28 | |
| 12/21/18 | S-3 | Registration statement for specified transactions by certain issuers |
|
43 | |
| 12/18/18 | 8-K | Current report filing |
|
3 | |
| 12/03/18 | 15-12G | Notice of termination of registration of a class of securities under Section 12(g) |
|
2 | |
| 11/28/18 | EFFECT | Notice of Effectiveness |
|
1 | |
| 11/28/18 | EFFECT | Notice of Effectiveness |
|
1 | |
| 11/28/18 | EFFECT | Notice of Effectiveness |
|
1 | |
| 11/26/18 | SC 13D | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
12 | |
| 11/23/18 | 8-K | Current report filing |
|
3 |
